Leadless Pacemaker Implantation During Extraction in Patients with Active Infection: A Comprehensive Analysis of Safety, Patient Benefits and Costs
Journal of Clinical Medicine · 02.08.2025 · 14 (15) · 5450
DOI: 10.3390/jcm14155450 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 02.08.2025. Verfasst von Aviv Solomon und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Chaim Sheba Medical Center, Leviev Heart Institute, Tel Hashomer, Ramat Gan 5262000, Israel. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cardiac implantable electronic device (CIED) infections necessitate extraction and subsequent pacing interventions. Conventional methods after removing the infected CIED system involve temporary or semi-permanent pacing followed by delayed permanent pacemaker (PPM) implantation. Leadless pacemakers (LPs) may offer an alternative, allowing immediate PPM implantation without increasing infection risks. Our objective is to evaluate the safety and cost-effectiveness of LP implantation during the same procedure of CIED extraction, compared to conventional two-stage approaches.
Methods
Pacemaker-dependent patients with systemic or pocket infection undergoing device extraction and LP implantation during the same procedure at Sheba Medical Center, Israel, were compared to a historical group of patients undergoing a semi-permanent (SP) pacemaker implantation during the procedure, followed by a permanent pacemaker implantation.
Results
The cohort included 87 patients, 45 undergoing LP implantation and 42 SP implantation during the extraction procedure. The LP group demonstrated shorter intensive care unit stay (1 ± 3 days vs. 7 ± 12 days, p < 0.001) and overall hospital days (11 ± 24 days vs. 17 ± 17 days, p < 0.001). Rates of infection relapse and one-year mortality were comparable between groups. Economic analysis revealed comparable total costs, despite the higher initial expense of LPs.
Conclusions
LP implantation during CIED extraction offers significant clinical and logistical advantages, including reduced hospital stays and streamlined treatment, with comparable safety and cost-effectiveness to conventional approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Chaim Sheba Medical Center, Leviev Heart Institute, Tel Hashomer, Ramat Gan 5262000, Israel.
- School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
ORCID-Profile: Aviv Solomon, Anat Berkovitch
Zitieren
APA
Solomon, A., Tzuberi, M., Berkovitch, A., Hoch, E., Beinart, R., & Nof, E. (2025). Leadless Pacemaker Implantation During Extraction in Patients with Active Infection: A Comprehensive Analysis of Safety, Patient Benefits and Costs. Journal of Clinical Medicine, 14(15), 5450. https://doi.org/10.3390/jcm14155450
Vancouver
Solomon A, Tzuberi M, Berkovitch A, Hoch E, Beinart R, Nof E. Leadless Pacemaker Implantation During Extraction in Patients with Active Infection: A Comprehensive Analysis of Safety, Patient Benefits and Costs. Journal of Clinical Medicine. 2025;14(15):5450. doi:10.3390/jcm14155450
BibTeX
@article{Solomon2025,
author = {Solomon, Aviv and Tzuberi, Maor and Berkovitch, Anat and Hoch, Eran and Beinart, Roy and Nof, Eyal},
title = {Leadless Pacemaker Implantation During Extraction in Patients with Active Infection: A Comprehensive Analysis of Safety, Patient Benefits and Costs},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {15},
pages = {5450},
doi = {10.3390/jcm14155450}
}
EUVIMED